MSGDDDIPEG LEAINLKMNA TTDDSLESTR RMLALCEESK EAGIKTLVML DDQGEQLERCEGALDTINQD MKEAEDHLKG MEKCCGLCVL PWNKTDDFEK TEFAKAWKKD DDGGVISDQPRITVGDSSMG PQGGYITKIT NDAREDEMDE NVQQVSTMVG NLRNMAIDMS TEVSNQNRQL DRIHDKAQSN EVRVESANKR AKNLITK

Voraussichtliches MW

23 kDa

Reinheit

>95% as determined by SDS-PAGE.

Produktform

Liquid

Konzentration

Lot Specific

Formulierung

Supplied in 20 mM Tris HCl Buffer, pH 7.5, with 50 mM Sodium Chloride, 5 mM DTT, 1 mM EDTA, and 10% Glycerol.

Lagerung

Shipped at 4°C. Short term (2-4 weeks) store at 4°C. Long term store at -20°C, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid freeze/thaw cycles.

Synonyme

bA416N4.2, Bdr, CMS18, dJ1068F16.2, FLJ23079, HGNC:11132, MGC105414, MGC139754, Resistance to inhibitors of cholinesterase 4 homolog, RIC 4, RIC4, SEC 9, SEC9, SNAP, SNAP 25, SNAP-25, SNAP-25B, SNP 25, SNP25, SNP25_HUMAN, sp, SUP, Super protein, Synaptosomal associated 25 kDa protein, Synaptosomal associated protein, Synaptosomal associated protein 25, Synaptosomal associated protein 25kDa, Synaptosomal-associated 25 kDa protein, Synaptosomal-associated protein 25, Synaptosomal-associated protein, 25-KD

Haftungsausschluss

Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.